Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic Conjunctivitis

Condition:   Seasonal Allergic Conjunctivitis Interventions:   Drug: Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic Solution;   Drug: Ketotifen fumarate ophthalmic solution 0.035% (n = 56);   Drug: Brimonidine tartrate ophthalmic solution 0.025% (n = 56);   Drug: Experimental: Vehicle ophthalmic solution (n = 56) Sponsor:   Bausch & Lomb Incorporated Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials